跳至主要内容
临床试验/NCT00392730
NCT00392730已完成不适用

Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children

Vanderbilt University1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2006年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
122
试验地点
1
主要终点
Brain Mn deposition measured by MR relaxometry

研究概览

简要总结

Manganese (Mn) is an essential metal required for normal growth and development. However, exposure to high Mn levels can be toxic to the brain. The objectives of this project are to identify neonatal and young pediatric populations that are at increased risk of excessive brain Mn deposition and altered cognitive and motor development based on their dietary parenteral Mn exposure, and to make sound and evidence-based recommendations for appropriate Mn supplementation and monitoring of infants and young children receiving parenteral nutrition (PN). Our studies are designed to test the hypotheses that, compared with unexposed age-matched controls, infants and young children receiving prolonged Mn-supplemented PN will have increased deposition of Mn in their brains and lower scores on neurodevelopmental, cognitive and psychophysiological assessments.

详细描述

Specific Aims have been designed to test these hypotheses in three developmentally distinct populations:

  1. preterm infants and
  2. full term infants in the Neonatal Intensive Care Unit (NICU) requiring prolonged PN and
  3. older infants and young children on home PN.

Mn neurotoxicity will be investigated by longitudinal assessments of cognitive (executive functioning battery), neurodevelopmental (Bayley III Scales of Infant Development), and psychophysiological (event-related potential) measures and will be correlated with brain deposition of Mn using the technique of magnetic resonance (MR) relaxometry in a vulnerable population of infants receiving Mn-supplemented PN and age-matched controls. This proposal addresses a clinically relevant and unexplored link between nutritional practices, brain Mn deposition and neurodevelopmental sequelae in an at-risk population of infants and young children utilizing state-of-the-art magnetic resonance imaging (MRI) technology and neurodevelopmental assessment techniques. The potential for increased brain Mn accumulation in infants, and by inference, the potential health risks associated with elevated brain Mn burden, represents crucial, unexplored issues of exposure and susceptibility. The potential contribution of Mn toxicity to the poor outcomes of infants dependent for an extended time on PN has not been fully acknowledged or studied. Improved understanding of the relationships between Mn exposure and developmental outcomes will undoubtedly lead to altered clinical practices and more careful monitoring of Mn intake and blood and/or brain Mn levels in high risk infants. Our studies will also contribute to an improved understanding of the value of non-invasive MR imaging in the monitoring of pediatric patients on PN.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
30 Days 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Greater than 30 days postnatal age
  • In the preceding four weeks, have received >75% of their nutrition as Mn-supplemented PN
  • Clinically stable for transport to the MR facility
  • Signed parental consent.
  • Or healthy age-matched controls

排除标准

  • Any infant not expected to survive to the age of 3 months or
  • Not expected to achieve sufficient clinical stability to tolerate the MRI procedure.

结局指标

主要结局

Brain Mn deposition measured by MR relaxometry

时间窗: baseline (at study enrolment)

Mn neurotoxicity will be investigated by magnetic resonance (MR) relaxometry in a population of infants receiving Mn-supplemented parenteral nutrition and age-matched controls.

次要结局

  • Neurodevelopmental outcomes(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Judy Aschner

Adjunct Professor of Pediatrics

Vanderbilt University

研究点 (1)

Loading locations...

相似试验